nach oben

Erschienen in:

21.02.2017 | Original Article

Preparedness and Cancer-Related Symptom Management among Cancer Survivors in the First Year Post-Treatment

verfasst von: Corinne R. Leach, PhD, MS, MPH, Alyssa N. Troeschel, MPH, Dawn Wiatrek, PhD, Annette L. Stanton, PhD, Michael Diefenbach, PhD, Kevin D. Stein, PhD, Katherine Sharpe, MTS, Kenneth Portier, PhD

Erschienen in: Annals of Behavioral Medicine | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Many cancer survivors feel unprepared for the physical and psychosocial challenges that accompany the post-treatment care transition (i.e., re-entry phase), including management of cancer-related symptoms. Few studies have investigated personal and contextual factors associated with the extent of preparedness for re-entry or how they are related to cancer-related symptom management.

Purpose

Data from the American Cancer Society’s Cancer Survivor Transition Study examined (1) characteristics of breast, prostate, and colorectal cancer survivors (n = 1188) within the first year of completing treatment who are most and least prepared for re-entry; and (2) how preparedness level and other characteristics are related to cancer-related symptom management.

Methods

Stanton and colleagues’ [1] conceptual model of survivorship guided the selection of interpersonal/environmental, individual, and disease/treatment-related characteristics as potential contributors to levels of preparedness and cancer-related symptom management using regression tree and multivariate linear regression analyses.

Results

Survivors, on average, felt moderately prepared for the transition to post-treatment care. Lowest levels of preparedness were found among survivors with relatively high depressive symptoms, low perceived quality of oncology-provided survivorship care, and limited discussion about potential side effects with a health professional. Poorer symptom management was associated with younger age, having more comorbid conditions, and lower preparedness, social support, and spirituality.

Conclusion

Survivors who feel unprepared for the transition to post-treatment care report poorer cancer-related symptom management. Identification of factors associated with low perceived preparedness and poor cancer-related symptom management will assist in risk stratification and development of tailored interventions to meet the needs of cancer survivors during re-entry.

Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR. Promoting adjustment after treatment for cancer. Cancer. 2005; 104: 2608–13.CrossRefPubMed

Miller KD, Siegel R, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66: 271–89.CrossRefPubMed

Patrick DL, Ferketich SL, Frame PS, et al. National Institutes of Health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003; 95: 1110–7.CrossRefPubMed

Mullan F. Re-entry: The educational needs of the cancer survivor. Health Educ Q. 1984; 10 Suppl: 88–94.PubMed

Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012; 30: 1215–20.CrossRefPubMed

Henselmans I, Helgeson VS, Seltman H, de Vries J, Sanderman R, Ranchor AV. Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol. 2010; 29: 160–8.CrossRefPubMed

Hou WK, Law CC, Yin J, Fu YT. Resource loss, resource gain, and psychological resilience and dysfunction following cancer diagnosis: a growth mixture modeling approach. Health Psychol. 2010; 29: 484–95.CrossRefPubMed

Stanton AL, Ganz PA, Kwan L, et al. Outcomes from the moving beyond cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol. 2005; 23: 6009–18.CrossRefPubMed

Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol. 2006; 24: 5132–7.CrossRefPubMed

10.

Parry C, Morningstar E, Kendall J, Coleman EA. Working without a net: leukemia and lymphoma survivors’ perspectives on care delivery at end-of-treatment and beyond. J Psychosoc Oncol. 2011; 29: 175–98.CrossRefPubMed

11.

Schulman-Green D, Bradley EH, Knobf MT, Prigerson H, DiGiovanna MP, McCorkle R. Self-management and transitions in women with advanced breast cancer. J Pain Symptom Manage. 2011; 42: 517–25.CrossRefPubMedPubMedCentral

12.

Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363: 733–742.CrossRefPubMed

13.

Jones JM, Cheng T, Jackman M, Rodin G, Walton T, Catton P. Self-efficacy, perceived preparedness, and psychological distress in women completing primary treatment for breast cancer. J Psychosoc Oncol. 2010; 28: 269–90.CrossRefPubMed

14.

Garofalo JP, Choppala S, Hamann HA, Gjerde J. Uncertainty during the transition from cancer patient to survivor. Cancer Nurs. 2009; 32: E8–14.CrossRefPubMedPubMedCentral

15.

Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall; 1986: 642 p.

16.

Smith T, Stein KD, Mehta CC, et al. The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer. 2007; 109: 1–12.CrossRefPubMed

17.

Willis GB. Cognitive interviewing: A tool for improving questionnaire design: A tool for improving questionnaire design. Thousand Oaks, CA: SAGE Publications; 2004: 367 p.

18.

Fillenbaum GG. Multidimensional functional assessment of older adults: The Duke Older Americans Resources and Services Procedures. London, UK: Psychology Press; 2013. 186 p.

19.

Portenoy RK, Thaler HT, Kornblith AB, et al. The memorial symptom assessment scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A: 1326–36.CrossRefPubMed

20.

Cohen S, Mermelstein R, Kamarck T, Hoberman H. Measuring the functional components of social support [Internet]. In: Sarason I, Sarason B, editors. Social support: Theory, research and applications. Springer Netherlands; 1985. p. 73–94.Available from: http://dx.doi.org/10.1007/978-94-009-5115-0_5.

21.

Wenzel, L, Dogan-Ates, A, Habbal, R, et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005; 34: 94–98. CrossRef

22.

Carpenter, KM, Fowler, JM, Maxwell, GL, & Andersen, BL. Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med. 2010; 39(1): 79–90.CrossRefPubMedPubMedCentral

23.

Mao JJ, Bowman MA, Stricker CT, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009; 27: 933–8.CrossRefPubMed

24.

Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy—spiritual well-being scale (FACIT-Sp). Ann Behav Med. 2002; 24: 49–58.CrossRefPubMed

25.

Chopra, I, & Kamal, KM. A systematic review of quality of life instruments in long-term breast cancer survivors. Health qual life out. 2012; 10(1): 1.CrossRef

26.

Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health. 2002; 17: 1–16.CrossRef

27.

Dempster, M, McCorry, NK, Brennan, E., Donnelly, M, Murray, LJ, & Johnston, BT. Psychological distress among family carers of oesophageal cancer survivors: the role of illness cognitions and coping. Psycho-Oncology. 2011; 20(7): 698–705.CrossRefPubMed

28.

Andersen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994; 10(2): 77–84.

29.

Conerly, R. C., Baker, F., Dye, J., Douglas, C. Y., & Zabora, J. Measuring depression in African American cancer survivors: The reliability and validity of the Center for Epidemiologic Study—Depression (CES-D) scale. J Health Psychol. 2002; 7(1): 107–114.CrossRefPubMed

30.

Eaton, W. W., Muntaner, C., & Smith, C. (2004). Centre for Epidemiologic Studies Depression Scale–Revised (CESD–R). Innovations in clinical practice: A source book (eds L VandeCreek, T Jackson), 295–7.

31.

Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473–83.CrossRefPubMed

32.

Chin MP, Wrolstad D, Bakris GL, et al. Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. J Card Fail. 2014; 20: 953–8.CrossRefPubMed

33.

Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ. ADHERE scientific advisory committee, study group, and investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005; 293: 572–80.CrossRefPubMed

34.

Kobayashi D, Yokota K, Takahashi O, Arioka H, Fukui T. A predictive rule for mortality of inpatients with Staphylococcus aureus bacteraemia: A classification and regression tree analysis. Eur J Intern Med. 2014; 25: 914–8.CrossRefPubMed

35.

Brombin C, Diomede L, Tudor D, et al. A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients. PloS One. 2013; 8: e58768.CrossRefPubMedPubMedCentral

36.

Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med. 2003; 26: 172–81.CrossRefPubMed

37.

From cancer patient to cancer survivor: Lost in transition [Internet]. Washington, D.C.: National Academies Press; 2005 [cited 2016 Mar 7]. Available from: http://www.nap.edu/catalog/11468.

38.

Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014; 32: 1605–19.CrossRefPubMedPubMedCentral

39.

Curran SL, Andrykowski MA, Studts JL. Short form of the profile of mood states (POMS-SF): Psychometric information. Psychol Assess. 1995; 7: 80–3.CrossRef

40.

McNair DM, Lorr M, Droppleman LF. EITS manual for the profile of mood states. Educational and Industrial Testing Service; 1971: 27 p.

41.

Sun CC, Bodurka DC, Weaver CB, et al. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Supp Care Cancer. 2005; 13: 219–27.CrossRef

42.

Deshields TL, Potter P, Olsen S, Liu J. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Supp Care Cancer. 2014; 22: 1089–96.CrossRef

43.

Akin S, Can G, Aydiner A, Ozdilli K, Durna Z. Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy. Eur J Oncol Nurs. 2010; 14: 400–9.CrossRefPubMed

44.

Bardwell WA, Natarajan L, Dimsdale JE, et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol. 2006; 24: 2420–7.CrossRefPubMed

45.

Wu HS, Harden JK. Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs. 2015; 38(1): E29–54.CrossRefPubMed

46.

Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2011. 117(12): 2779–2790.CrossRefPubMedPubMedCentral

47.

Yanez B, Edmondson D, Stanton AL, et al. Facets of spirituality as predictors of adjustment to cancer: relative contributions of having faith and finding meaning. J Consult Clin Psychol. 2009; 77: 730–41.CrossRefPubMedPubMedCentral

48.

Hamrick N, Diefenbach MA. Religion and spirituality among patients with localized prostate cancer. Palliat Supp Care. 2006; 4: 345–55.

Titel: Preparedness and Cancer-Related Symptom Management among Cancer Survivors in the First Year Post-Treatment
verfasst von: Corinne R. Leach, PhD, MS, MPH
Alyssa N. Troeschel, MPH
Dawn Wiatrek, PhD
Annette L. Stanton, PhD
Michael Diefenbach, PhD
Kevin D. Stein, PhD
Katherine Sharpe, MTS
Kenneth Portier, PhD
Publikationsdatum: 21.02.2017
Verlag: Springer US
Erschienen in: Annals of Behavioral Medicine / Ausgabe 4/2017
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-017-9880-6

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Preparedness and Cancer-Related Symptom Management among Cancer Survivors in the First Year Post-Treatment